ABOS logo

Acumen Pharmaceuticals (ABOS) Company Overview

Profile

Full Name:

Acumen Pharmaceuticals, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

July 1, 2021

Indexes:

Not included

Description:

Acumen Pharmaceuticals focuses on developing innovative treatments for Alzheimer's disease. The company aims to create therapies that target the underlying causes of the disease, improving patients' quality of life. Their research combines advanced science with a commitment to addressing the needs of those affected by Alzheimer's.

Events Calendar

Earnings

Next earnings date:

Mar 26, 2025

Recent quarterly earnings:

Nov 12, 2024

Recent annual earnings:

Mar 26, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Nov 13, 24 HC Wainwright & Co.
Buy
Oct 3, 24 HC Wainwright & Co.
Buy
Aug 15, 24 UBS
Buy
Aug 14, 24 HC Wainwright & Co.
Buy
Jul 25, 24 Citigroup
Buy
May 15, 24 HC Wainwright & Co.
Buy
Mar 31, 24 UBS
Buy
Mar 27, 24 HC Wainwright & Co.
Buy
Dec 12, 23 Deutsche Bank
Buy
Aug 9, 23 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Acumen Pharmaceuticals?
  • Does Acumen Pharmaceuticals pay dividends?
  • What sector is Acumen Pharmaceuticals in?
  • What industry is Acumen Pharmaceuticals in?
  • What country is Acumen Pharmaceuticals based in?
  • When did Acumen Pharmaceuticals go public?
  • Is Acumen Pharmaceuticals in the S&P 500?
  • Is Acumen Pharmaceuticals in the NASDAQ 100?
  • Is Acumen Pharmaceuticals in the Dow Jones?
  • When was Acumen Pharmaceuticals's last earnings report?
  • When does Acumen Pharmaceuticals report earnings?
  • Should I buy Acumen Pharmaceuticals stock now?

What is the ticker symbol for Acumen Pharmaceuticals?

The ticker symbol for Acumen Pharmaceuticals is NASDAQ:ABOS

Does Acumen Pharmaceuticals pay dividends?

No, Acumen Pharmaceuticals does not pay dividends

What sector is Acumen Pharmaceuticals in?

Acumen Pharmaceuticals is in the Healthcare sector

What industry is Acumen Pharmaceuticals in?

Acumen Pharmaceuticals is in the Biotechnology industry

What country is Acumen Pharmaceuticals based in?

Acumen Pharmaceuticals is headquartered in United States

When did Acumen Pharmaceuticals go public?

Acumen Pharmaceuticals's initial public offering (IPO) was on July 1, 2021

Is Acumen Pharmaceuticals in the S&P 500?

No, Acumen Pharmaceuticals is not included in the S&P 500 index

Is Acumen Pharmaceuticals in the NASDAQ 100?

No, Acumen Pharmaceuticals is not included in the NASDAQ 100 index

Is Acumen Pharmaceuticals in the Dow Jones?

No, Acumen Pharmaceuticals is not included in the Dow Jones index

When was Acumen Pharmaceuticals's last earnings report?

Acumen Pharmaceuticals's most recent earnings report was on Nov 12, 2024

When does Acumen Pharmaceuticals report earnings?

The next expected earnings date for Acumen Pharmaceuticals is Mar 26, 2025

Should I buy Acumen Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions